• $6.9M
    Market Cap
  • -68.25%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

N/A
No data found

No data found

Momentum Score

Score: 34
Valuation
KAYS
vs History
vs S&P 500
3-Month Momentum
-67.57%
12-Month Momentum
-73.00%
3-Month Risk Adjusted Momentum
-66.78%
12-Month Risk Adjusted Momentum
-28.13%

True Yield

N/A
No data found

No data found

Financial Health Score

N/A
No data found

No data found